Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00746668 · ClinicalTrials.gov registry record · NA
A Multi-Center Study of Reading Rehabilitation in Macular Disease
A NA study of Retinal Degeneration and Age-related Maculopathy, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT00746668 is a NA study of Retinal Degeneration and Age-related Maculopathy that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 36 participants, below the 339-participant average among 17 other Retinal Degeneration trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00746668, a NA study of Retinal Degeneration and Age-related Maculopathy, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to measure the effectiveness of a newly-designed oculomotor training program for patients with macular disease, including age-related macular degeneration.
Conditions Studied
Interventions
- BEHAVIORAL Module 1: Visual Awareness and Eccentric Viewing
- BEHAVIORAL Module 2: Control of Reading Eye Movements
- BEHAVIORAL Module 3: Reading Practice with RSVP
Study Locations (1)
Illinois
- Jesse Brown VAMC (WestSide Division) - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2008-08 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00746668
The ClinicalTrials.gov registry entry for NCT00746668 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 339-participant average among 17 other Retinal Degeneration trials with a reported enrollment target (89% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Retinal Degeneration appearing as the primary indexed condition, and to 3 interventions - of which Module 1: Visual Awareness and Eccentric Viewing is the first listed.
NCT00746668 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00746668 about?
NCT00746668 is a clinical study titled "A Multi-Center Study of Reading Rehabilitation in Macular Disease". The purpose of this study is to measure the effectiveness of a newly-designed oculomotor training program for patients with macular disease, including age-related macular degeneration.
What is the current status of trial NCT00746668?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2008-08. Estimated completion is 2012-09.
What conditions does trial NCT00746668 study?
This clinical trial studies the following conditions: Retinal Degeneration, Age-related Maculopathy.
What interventions are being tested in trial NCT00746668?
The interventions under investigation include: Module 1: Visual Awareness and Eccentric Viewing (BEHAVIORAL), Module 2: Control of Reading Eye Movements (BEHAVIORAL), Module 3: Reading Practice with RSVP (BEHAVIORAL).
Who is sponsoring clinical trial NCT00746668?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00746668 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinal Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SGLT2 Inhibitors in Geographic Atrophy
RECRUITING · Phase 2
-
Cell Collection to Study Eye Diseases
RECRUITING
-
A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001
RECRUITING · Phase 1
-
Adaptive Optics Imaging of Outer Retinal Diseases
RECRUITING
-
Rod and Cone Mediated Function in Retinal Disease
RECRUITING
-
Oral Metformin for Treatment of ABCA4 Retinopathy
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.